FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry. Disclosed is a method of producing a composition for inhibiting activity β-glucuronidase, according to which a phosphate buffer solution of a copolymer of vinyl pyrrolidone and vinyl amine (containing 90 mol. % vinyl pyrrolidone units and 10 mol. % vinyl amine units) with concentration thereof in solution of 10–12 wt. %, preparing a phosphate buffer solution of mixture of 1,4- and 3,6-lactones of D-sugar acid with ratio of 40–60/60–40 wt. % with concentration in solution of 21.5–24.0 wt. %, then obtained solutions are mixed, then combined solution is treated with 25 % sodium hydroxide solution to pH equal to 4.8–4.9, at 20–25 °C and lyophilic drying said solution.
EFFECT: invention provides higher inhibition efficiency β-glucuronidase with prolonged action of obtained composition.
1 cl, 4 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCT SYNTHESIS | 1992 |
|
RU2057532C1 |
CANCER PREVENTING AGENT | 1999 |
|
RU2159109C1 |
COMPOSITIONS AND METHODS OF TREATING BLADDER CANCER | 2008 |
|
RU2542449C2 |
COPOLYMER CONTAINING N-VINYL PYRROLIDONE, 2-METHYL-5-VINYL PYRIDINE AND 4-VINYL PYRIDINE LINKS | 2011 |
|
RU2459838C1 |
METHOD FOR PRODUCING AN ACIDIC POTASSIUM SALT OF D-GLUCARIC ACID AND AN INSTALLATION FOR ITS IMPLEMENTATION | 2021 |
|
RU2757109C1 |
METHODS FOR TREATMENT OF BLADDER CANCER | 2019 |
|
RU2795220C2 |
HETEROPOLYSACCHARIDES DERIVED FROM WOODY PLANTS FOR USE IN TREATING UROLOGIC SYMPTOMS AND DISEASES | 2013 |
|
RU2687585C2 |
THERAPEUTIC POLYMERIC NANOPARTICLES AND METHODS OF MAKING AND USING SAME | 2014 |
|
RU2682332C2 |
PREPARATION FLAVOSUCCINE FOR TREATING AND PREVENTING RENAL AND URINARY DISEASES | 2010 |
|
RU2456011C1 |
PREPARATIONS OF THERMO-ABRASIVE HYDROGEL FOR APPLICATION IN TREATMENT OF UTERTAL DISORDERS | 2013 |
|
RU2635466C2 |
Authors
Dates
2020-06-18—Published
2019-04-19—Filed